Search Results 611-620 of 17620 for Prednisone

1. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

   Must be on a stable dose of oral prednisolone or prednisone of ≥ 7.5 mg/day (but not > 50mg/day) for at least 4 weeks prior to randomization. If receiving ...

2. Rifampin and isoniazid (oral route) - Side effects & dosage - Mayo Clinic

   Prednisone; Raltegravir; Repaglinide; Rofecoxib; Sertraline; Triazolam; Trimetrexate. Show More. Other Interactions. Certain medicines should not be used at or ...

3. Mayo Clinic

   ... . VID-20522544. Home; Clubfoot. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 ...

4. Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. - Mayo Clinic

   Subjects taking corticosteroids during the last 1 week prior treatment, unless administered at a dose equivalent to < 20 mg/day of prednisone; Systemic anti ...

5. Drugs and Supplements that Start with P - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “P” to learn about drug side effects, proper use and ...

6. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

   ... prednisone-equivalent for > 14 days, within 6 months of screening. Note: Subjects required to take or who have taken a dose of ≤ 10 mg/day prednisone ...

7. A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab - Mayo Clinic

   ... prednisone for patients >= 18 years or > 0.5 mg/kg [up to 10 mg/day] for ... prednisone equivalents) are permitted in the absence of active autoimmune disease ...

8. A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS - Mayo Clinic

   ... prednisone therapy at ≥ 1 mg/kg/day, a trial of calcineurin inhibitor for=> 3 months or a contraindication/intolerance to such therapy (diabetes ...

9. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V - Mayo Clinic

   disease. Participants being treated with systemic corticosteroids for SLE or LN will be excluded if they have taken more than an average of 10 mg/day prednisone ...

10. Adrenalectomy - Doctors & Departments - Mayo Clinic

    Learn what to expect from this surgery that involves removing an adrenal gland.